BibTex RIS Kaynak Göster

Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?

Yıl 2013, Cilt: 26 Sayı: 3, 176 - 177, 30.09.2015
https://doi.org/10.5472/MMJ.2013.02828.1

Öz

Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?

Kaynakça

  • Shreve P, Anzai Y, Wahl R. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999;19:61–77.
  • Cook GJR, Fogelman I, Maisey M. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron emission tomography scanning: potential for error in interpretation. Semin Nucl Med 1996;24:308-14. doi: 10.1016/S0001-2998(96)80006-7
  • Bischof-Delaloye A, Wahl RL. How high a level of FDG abdominal activity is considered normal? J Nucl Med 1995; 36(suppl):106P. Horton KM, Fishman EK. Helical CT of the stomach: evaluation with water as an oral contrast agent. AJR 1998;171:1373-6. doi: 10.2214/ ajr.15.9798881
  • Mijin Y, Hyun S C, Eunhye Y, et al. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET. J Nucl Med 2005;46:953-7.

Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?

Yıl 2013, Cilt: 26 Sayı: 3, 176 - 177, 30.09.2015
https://doi.org/10.5472/MMJ.2013.02828.1

Öz

-

Kaynakça

  • Shreve P, Anzai Y, Wahl R. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999;19:61–77.
  • Cook GJR, Fogelman I, Maisey M. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron emission tomography scanning: potential for error in interpretation. Semin Nucl Med 1996;24:308-14. doi: 10.1016/S0001-2998(96)80006-7
  • Bischof-Delaloye A, Wahl RL. How high a level of FDG abdominal activity is considered normal? J Nucl Med 1995; 36(suppl):106P. Horton KM, Fishman EK. Helical CT of the stomach: evaluation with water as an oral contrast agent. AJR 1998;171:1373-6. doi: 10.2214/ ajr.15.9798881
  • Mijin Y, Hyun S C, Eunhye Y, et al. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET. J Nucl Med 2005;46:953-7.
Toplam 4 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Bölüm Makaleler
Yazarlar

Salih Özgüven Bu kişi benim

Yayımlanma Tarihi 30 Eylül 2015
Yayımlandığı Sayı Yıl 2013 Cilt: 26 Sayı: 3

Kaynak Göster

APA Özgüven, S. (2015). Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?. Marmara Medical Journal, 26(3), 176-177. https://doi.org/10.5472/MMJ.2013.02828.1
AMA Özgüven S. Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?. Marmara Med J. Eylül 2015;26(3):176-177. doi:10.5472/MMJ.2013.02828.1
Chicago Özgüven, Salih. “Is the Presence of Diffuse Gastric Hypermetabolism Enough to Exclude a Gastric Tumour?”. Marmara Medical Journal 26, sy. 3 (Eylül 2015): 176-77. https://doi.org/10.5472/MMJ.2013.02828.1.
EndNote Özgüven S (01 Eylül 2015) Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?. Marmara Medical Journal 26 3 176–177.
IEEE S. Özgüven, “Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?”, Marmara Med J, c. 26, sy. 3, ss. 176–177, 2015, doi: 10.5472/MMJ.2013.02828.1.
ISNAD Özgüven, Salih. “Is the Presence of Diffuse Gastric Hypermetabolism Enough to Exclude a Gastric Tumour?”. Marmara Medical Journal 26/3 (Eylül 2015), 176-177. https://doi.org/10.5472/MMJ.2013.02828.1.
JAMA Özgüven S. Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?. Marmara Med J. 2015;26:176–177.
MLA Özgüven, Salih. “Is the Presence of Diffuse Gastric Hypermetabolism Enough to Exclude a Gastric Tumour?”. Marmara Medical Journal, c. 26, sy. 3, 2015, ss. 176-7, doi:10.5472/MMJ.2013.02828.1.
Vancouver Özgüven S. Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?. Marmara Med J. 2015;26(3):176-7.